Murine Malaria Is Exacerbated by CTLA-4 Blockade1

Murine Malaria Is Exacerbated by CTLA-4 Blockade1
复制标题

CTLA-4 封锁加剧了小鼠疟疾1

DOI:
--
复制
发表时间:
2002
影响因子:
4.4
通讯作者:
B. Fleischer
B. Fleischer
中科院分区:
医学2区
文献类型:
--
作者:
T. Jacobs;S. Graefe;Sonja Niknafs;Iris Gaworski;B. Fleischer

文献摘要

参考文献

被引文献

相似文献

溶细胞 T 淋巴细胞相关 Ag-4 (CD152) 是一种负调节分子,主要在 T 细胞激活后表达。在这项研究中,我们研究了 CTLA-4 表达在实验性血期疟疾中的作用。与人类疟疾类似,感染伯氏疟原虫后,C57BL/6 小鼠的 CD4+ T 细胞上表达 CTLA-4。动力学分析显示,CTLA-4 表达在感染后第 5 天增加,并在感染后第 9 天达到峰值,此时几乎 10% 的脾 CD4+ T 细胞表达 CTLA-4。通过特定的单克隆抗体在体内阻断 CTLA-4 并随后用伯氏疟原虫进行攻击,会引起让人想起小鼠脑型疟疾和早期死亡的神经系统症状。对抗 CTLA-4 治疗小鼠脑切片的组织学检查显示出出血和水肿等病理变化,而对照组小鼠则没有这些变化。此外,抗 CTLA-4 治疗还逆转了血期疟疾期间 CD4+ T 细胞的大量损失和 T 细胞反应的抑制。我们的数据表明,CTLA-4 表达通过限制疟疾期间 T 细胞的激活来预防免疫病理。他们还表明,脑型疟疾的发生是由于未能下调 T 细胞活化而介导的。
Cytolytic T lymphocyte-associated Ag-4 (CD152) is a negatively regulating molecule, which is primarily expressed on T cells following their activation. In this study, we have examined the role of CTLA-4 expression in experimental blood-stage malaria. Similar to human malaria, CTLA-4 is expressed on CD4+ T cells of C57BL/6 mice after infection with Plasmodium berghei. A kinetic analysis revealed that CTLA-4 expression was increased on day 5 postinfection and reached a peak on day 9 postinfection, when almost 10% of splenic CD4+ T cells expressed CTLA-4. Blockade of CTLA-4 in vivo by a specific mAb and subsequent challenge with P. berghei caused neurological signs reminiscent of murine cerebral malaria and earlier death. Histologic examination of brain sections from anti-CTLA-4-treated mice revealed pathologic changes such as hemorrhages and edema, which were absent in control mice. Furthermore, treatment with anti-CTLA-4 also reversed the extensive loss of CD4+ T cells and the suppressed T cell response occurring during blood-stage malaria. Our data suggest that CTLA-4 expression prevents immune pathology by restricting T cell activation during malaria. They also indicate that the development of cerebral malaria is mediated by a failure to down-regulate T cell activation.
DOI: 10.4049/jimmunol.143.6.2038
发表时间: 1989-09
影响因子: 4.4
作者:
H. Shear;R. Srinivasan;T. Nolan;C. Ng
通讯作者: H. Shear;R. Srinivasan;T. Nolan;C. Ng
DOI: 10.1016/1074-7613(95)90125-6
发表时间: 1995-11-01
期刊: IMMUNITY
影响因子: 32.4
作者:
TIVOL, EA;BORRIELLO, F;SHARPE, AH
通讯作者: SHARPE, AH
DOI: 10.1016/s1074-7613(00)80284-8
发表时间: 1997-04-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Perez, VL;VanParijs, L;Abbas, AK
通讯作者: Abbas, AK
DOI: 10.1073/pnas.95.17.10067
发表时间: 1998-08-18
影响因子: 11.1
作者:
Hurwitz, AA;Yu, TFY;Allison, JP
通讯作者: Allison, JP
DOI: 10.1016/s1074-7613(01)00097-8
发表时间: 2001-02-01
期刊: IMMUNITY
影响因子: 32.4
作者:
Greenwald, RJ;Boussiotis, VA;Sharpe, AH
通讯作者: Sharpe, AH